- GE Healthcare’s design for Deep Silicon detectors for a photon counting CT (PCCT) is engineered with the goal of achieving breakthroughs in both CT spatial and spectral resolution at the same time and increasing imaging performance across care areas
- Researchers at the University of Wisconsin–Madison will kick off research scanning human subjects with GE Healthcare’s latest generation PCCT prototype in December 2022, representing the first U.S.
For media inquiries, please contact:
Margaret Steinhafel
1 608 381 8829
[email protected]
business unit
- Omni Legend is an innovative, breakthrough technology built from the ground up to harness the power of an advanced digital detector capable of producing high-resolution images and exceptional image quality with enhanced clinical efficiency
- The Omni PET/CT platform accommodates patients across more care areas and offers a scalable design to easily enable future-ready capabilities and multi-dimensional scalability
- The new system is designed with Precision DL[i] – a new deep learning image processing software – and t
For media inquiries, please contact:
Margaret Steinhafel
GE Healthcare
+1 608 381 8829
[email protected]
business unit
- Artificial intelligence (AI) and healthcare access remain key themes at ISMRM as researchers and clinicians seek more efficient and effective solutions in today’s resource-constrained environment
- GE Healthcare highlights the continued expansion of its state-of-the-art AIR Recon DL technology across the totality of its 1.5T, 3.0T and 7.0T MR product portfolio
- Already, this democratization of AI has benefitted more than two million patients around the world and fundamentally shifted the balance between image quality and scan time in MR
For media inquiries, please contact:
Margaret Steinhafel
1 608 381 8829
[email protected]
business unit
- GE Healthcare introduces the industry’s first[i] computed tomography (CT) platform with built-in scalability and upgradability[ii]
- The new Revolution Apex platform offers the world’s fastest gantry speed: 0.23 seconds per rotation and 19.5 millisecond effective temporal resolution to freeze cardiac motion[iii]
- Altogether, the company’s CT platform enables healthcare facilities to keep up with the latest technology while minimizing technology obsolescence, optimizing clinical capabilities, and st
For media inquiries, please contact:
Margaret Steinhafel
+1 608 381 8829
[email protected]
America/Chicago
business unit
- Photon counting CT has the promise to further expand the capabilities of traditional CT
- Karolinska Institutet and MedTechLabs’ pilot study represents the first of its kind to test pure silicon CT detector technology for photon counting CT in a clinical setting
- The project is the result of close collaborations between healthcare, academia and business
Chicago, November 17, 2021: Karolinska Institutet and MedTechLabs recently started testing the world’s fir
For media inquiries, please contact:
Margaret Steinhafel1 608 381 8829
[email protected]
business unit
GE Healthcare invests in a unique approach to cutting-edge CT technology and acquires Prismatic Sensors AB, a leader in Deep Silicon detector technology for photon counting computed tomography (PCCT)
For media inquiries, please contact:
Margaret SteinhafelGE Healthcare
+1 608 381 8829
[email protected]
business unit
- Total orders of $28.7 billion, down 4%; organic orders up 4%; total revenues (GAAP) of $28.8 billion, down 1%; Industrial segment organic revenues (non-GAAP) of $27.7 billion, up 7%
- GE Industrial profit margin (GAAP) of (1.3)%; adjusted GE Industrial profit margin (non-GAAP) of 7.6%
- Continuing EPS (GAAP) of $(0.03); adjusted EPS (non-GAAP) of $0.17, including $0.06 benefit from tax audit resolution
- Non-cash goodwill impairment charge of $744 million pre-tax related to Grid Solutions equipment and services, resulting in $(0.09) impact to
business unit
tags
- Companies aim to develop jointly-branded clinical decision support software for faster, more accurate, more confident decision-making, enabling earlier diagnosis and individualized treatment
- Partnership will apply advanced analytics to in-vivo data from GE’s medical imaging and monitoring equipment with in-vitro data from Roche’s biomarker, tissue pathology, genomics and sequencing portfolio
Chicago, USA Jan 8, 2018 - GE Healthcare has entered into a strategic, long-term partnership with Roche (SIX: RO, ROG; OTCQX: RHHBY) to jointl